Florida 2022 Regular Session

Florida House Bill H0543

Introduced
11/9/21  
Refer
11/19/21  
Refer
11/19/21  
Refer
11/19/21  
Refer
2/15/22  
Refer
2/15/22  
Refer
2/24/22  
Refer
2/28/22  
Engrossed
3/4/22  
Refer
3/4/22  
Engrossed
3/4/22  
Enrolled
3/4/22  
Passed
4/6/22  

Caption

Uterine Fibroid Research and Education

Impact

The introduction of this bill is set to create a more robust framework for understanding and managing uterine fibroids within the state. By compiling a state-wide database, healthcare providers will be better equipped to contribute valuable data, thereby enhancing research outcomes. The bill emphasizes the distribution of educational materials that will inform the public about the risk factors associated with uterine fibroids and treatment methods available. This initiative is expected to positively impact women's health care in Florida by fostering awareness and promoting preventive measures.

Summary

House Bill 543 is an act designed to address issues related to uterine fibroids by establishing a comprehensive approach to research, education, and public awareness. The bill mandates the Florida Department of Health to develop and maintain an electronic database of information pertaining to uterine fibroids, including diagnosis, treatment options, incidence, and demographic data. This initiative aims to support research efforts while ensuring that women receive necessary information regarding uterine fibroid prevention and treatment.

Sentiment

The sentiment surrounding HB 543 appears to be largely positive, with legislative discussions showcasing a commitment to advancing women's health issues. Supporters of the bill underline the importance of targeted education and the value of collating research data to address health challenges faced by women. The proactive approach of creating a resource for both practitioners and patients has received commendation from various advocacy groups aimed at protecting women's health rights.

Contention

Although the overall sentiment is supportive, there are concerns regarding the potential challenges in implementation, particularly the timely and accurate submission of data by healthcare providers. Additionally, while the bill prohibits the inclusion of personally identifiable information in the database, there may still be apprehensions regarding data privacy and how the information gathered will be utilized in the long term. Stakeholders will need to engage in continuous dialogue to address these issues and ensure that the bill achieves its intended goals without infringing on patient rights.

Companion Bills

FL S1010

Same As Uterine Fibroid Research and Education

Similar Bills

No similar bills found.